Showing results (111-120 of 242) with videos related to
Sort By:
Pageof 25
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2008
Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancerFred R Hirsch, Marileila Varella-Garcia, Rafal Dziadziuszko, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2005
Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancerChristiane D Thienelt, Paul A Bunn, Nasser Hanna, et al.Melanoma Research|August 29, 2024
Real-world evidence on efficacy and toxicity of targeted therapy in older melanoma patients treated in a tertiary-hospital settingRonen Stoff, Svetomir N Markovic, Robert R McWilliams, et al.Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
Ongoing and future trials of biologic therapies in lung cancerPaul A Bunn, Frances A Shepherd, Alan Sandler, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 30, 2012
Non-invasive breath analysis of pulmonary nodulesNir Peled, Meggie Hakim, Paul A Bunn, et al.Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Meta-analysis examining impact of age on overall survival with pemetrexed for the treatment of advanced non-squamous non-small cell lung cancerLuis G Paz-Ares, Annamaria Zimmermann, Tudor Ciuleanu, et al.Lung Cancer (Amsterdam, Netherlands)|May 3, 2016
Malignant pleural disease is highly associated with subsequent peritoneal metastasis in patients with stage IV non-small cell lung cancer independent of oncogene statusTejas Patil, Dara L Aisner, Sinead A Noonan, et al.International Immunopharmacology|December 20, 2002
Bradykinin antagonists as new drugs for prostate cancerJohn M Stewart, Daniel C Chan, Vitalija Simkeviciene, et al.Nanomedicine : Nanotechnology, Biology, and Medicine|February 23, 2013
Volatile fingerprints of cancer specific genetic mutationsNir Peled, Orna Barash, Ulrike Tisch, et al.Investigational New Drugs|April 2, 2013
Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignanciesErin Schenk, Andrea E Wahner Hendrickson, Donald Northfelt, et al.Pageof 25